Wave Life Sciences (WVE) Liabilities and Shareholders Equity (2016 - 2025)
Historic Liabilities and Shareholders Equity for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to $241.4 million.
- Wave Life Sciences' Liabilities and Shareholders Equity fell 3267.08% to $241.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 526.59%. This contributed to the annual value of $352.2 million for FY2024, which is 2809.9% up from last year.
- Latest data reveals that Wave Life Sciences reported Liabilities and Shareholders Equity of $241.4 million as of Q3 2025, which was down 3267.08% from $252.4 million recorded in Q2 2025.
- In the past 5 years, Wave Life Sciences' Liabilities and Shareholders Equity ranged from a high of $358.5 million in Q3 2024 and a low of $146.4 million during Q4 2022
- Over the past 5 years, Wave Life Sciences' median Liabilities and Shareholders Equity value was $230.0 million (recorded in 2023), while the average stood at $235.5 million.
- As far as peak fluctuations go, Wave Life Sciences' Liabilities and Shareholders Equity plummeted by 3533.14% in 2021, and later surged by 8782.47% in 2023.
- Wave Life Sciences' Liabilities and Shareholders Equity (Quarter) stood at $207.0 million in 2021, then fell by 29.28% to $146.4 million in 2022, then skyrocketed by 87.82% to $274.9 million in 2023, then rose by 28.1% to $352.2 million in 2024, then crashed by 31.47% to $241.4 million in 2025.
- Its Liabilities and Shareholders Equity stands at $241.4 million for Q3 2025, versus $252.4 million for Q2 2025 and $288.3 million for Q1 2025.